תמונות העטיפה

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis

Background: Conbercept is a new anti-vascular endothelial growth factor (VEGF) drug. Here, we systematically conducted the efficacy, safety, compliance, and pharmacoeconomic evaluation of intravitreal conbercept (IVC) compared with other treatments in patients with neovascular age-related macular de...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
Main Authors:	Pengxiang Zhou (Author), Siqian Zheng (Author), Ente Wang (Author), Peng Men (Author), Suodi Zhai (Author)
פורמט:	ספר
יצא לאור:	Frontiers Media S.A., 2021-10-01T00:00:00Z.
נושאים:	article
גישה מקוונת:	Connect to this object online.
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים

Profile of conbercept in the treatment of neovascular age-related macular degeneration
מאת: Lu XM, et al.
יצא לאור: (2015)

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
מאת: Yinchen Shen, et al.
יצא לאור: (2022)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
מאת: Lorenzo Ferro Desideri, et al.
יצא לאור: (2023)

Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
מאת: Wang LP, et al.
יצא לאור: (2018)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
מאת: Sun T, et al.
יצא לאור: (2021)

Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration
מאת: Li W, et al.
יצא לאור: (2016)

The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
מאת: Xinyu Zhao, et al.
יצא לאור: (2021)

EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
מאת: Lu Cheng, et al.
יצא לאור: (2021)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
מאת: Cai S, et al.
יצא לאור: (2018)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
מאת: Kaiser SM, et al.
יצא לאור: (2021)

Comparison of morphometric changes in the chorioretinal complex after anti-VEGF treatment in patients with pathologic myopia versus those with neovascular age-related macular degeneration
מאת: O.M. Blavatska, et al.
יצא לאור: (2018)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
מאת: Jing Wang, et al.
יצא לאור: (2021)

Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
מאת: Liu Q, et al.
יצא לאור: (2023)

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
מאת: Yang S, et al.
יצא לאור: (2016)

Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics
מאת: Kim Ivana K, et al.
יצא לאור: (2011)

Application of Artificial Intelligence Models to Predict the Onset or Recurrence of Neovascular Age-Related Macular Degeneration
מאת: Francesco Saverio Sorrentino, et al.
יצא לאור: (2024)

Effect of conbercept or ranibizumab in the treatment of wet age-related macular degeneration
מאת: Dawei Zhang, et al.
יצא לאור: (2019)

Hypertensive disorders of pregnancy increase the risk of developing neovascular age-related macular degeneration in later life
מאת: Karen Curtin, et al.
יצא לאור: (2019)

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
מאת: Hussain RM, et al.
יצא לאור: (2021)

First-Year Real-Life Experience with Intravitreal Faricimab for Refractory Neovascular Age-Related Macular Degeneration
מאת: Wissam Aljundi, et al.
יצא לאור: (2024)

Secukinumab Associated Choroidal Neovascularization
מאת: Edward B Miller, et al.
יצא לאור: (2022)

Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis
מאת: Ling Liu, et al.
יצא לאור: (2022)

Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study
מאת: Anna-Maria Kubin, et al.
יצא לאור: (2024)

First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration
מאת: Alaa Din Abdin, et al.
יצא לאור: (2022)

Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration
מאת: Nadia Zakaria, et al.
יצא לאור: (2022)

The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration
מאת: A. F. Yusupov, et al.
יצא לאור: (2024)

Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
מאת: Natalie Jia Ying Yeo, et al.
יצא לאור: (2019)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
מאת: Nicola Ferrante, et al.
יצא לאור: (2022)

Evaluation of Aqueous Flare Intensity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-Related Macular Degeneration
מאת: Joanna Dolar-Szczasny, et al.
יצא לאור: (2021)

Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
מאת: Irmela Mantel, et al.
יצא לאור: (2020)

Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
מאת: Wei Q, et al.
יצא לאור: (2019)

Dihydroartemisinin Inhibits Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular AMD
מאת: Xun Li, et al.
יצא לאור: (2022)

Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats
מאת: Xiaoyu Li, et al.
יצא לאור: (2024)

The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration
מאת: Miller Joan W, et al.
יצא לאור: (2008)

Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
מאת: Jose Navarro-Partida, et al.
יצא לאור: (2021)

Edema macular cistoideo Macular cystoid edema
מאת: Blanca Nieve Rey Estévez, et al.
יצא לאור: (2010)

Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta‐analysis of randomized controlled trials
מאת: Pengxiang Zhou, et al.
יצא לאור: (2023)

Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison
מאת: Yun Zhang, et al.
יצא לאור: (2021)

Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series
מאת: Silvio Zuccarini, et al.
יצא לאור: (2022)

Contextualizing single‐arm trials with real‐world data: An emulated target trial comparing therapies for neovascular age‐related macular degeneration
מאת: Darren S. Thomas, et al.
יצא לאור: (2021)